BNR
Burning Rock Biotech Ltd
NASDAQ: BNR · HEALTHCARE · DIAGNOSTICS & RESEARCH
$17.00
+4.68% today
Updated 2026-04-30
Market cap
$222.76M
P/E ratio
—
P/S ratio
0.41x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$2 – $42
Volume
0.0M
Burning Rock Biotech Ltd (BNR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |